SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the pending FDA decision for Capricors Duchenne muscular dystrophy treatment deramiocel, with a letter from 28 HOPE-3 investigators urging approval and disputing the agencys interpretation of the trial data. Many traders are optimistic and discuss call activity and short-squeeze potential, while others stress that approval is uncertain and a rejection or delay remains possible.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias steep drop is part of a broader semiconductor selloff as traders weigh whether post-election calls for tighter data-center controls could slow AI infrastructure spending. The community is split between fears of a lasting AI-capex reset and dip buyers who argue the concerns are overblown and projects can shift elsewhere.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons quarterly results missed expectations and its full-year revenue outlook was cut, with federal procurement delays cited, driving a sharp selloff. Traders debate whether the reaction reflects weaker near-term growth and a rich valuation or creates a buying opportunity given the companys longer-term prospects.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

A sharp selloff in semiconductor and AI-linked stocks has drawn attention to SOXS, as traders debate concerns about AI and data-center spending, sector valuations, and election-related policy uncertainty. Some expect more downside in chips, while others warn of a sharp rebound and note that SOXSs leverage and daily resets make it a volatile short-term trade.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a sharp semiconductor selloff as traders worry that post-election scrutiny of data-center construction could slow AI infrastructure spending and chip demand. The community is split between viewing the drop as an overreaction and buying opportunity, and expecting further downside amid AI-bubble and memory-cycle concerns.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs quarterly results showed rapid growth in its AI cloud business and a large contracted backlog, but the rollout of its more than $4 billion annualized-revenue target was pushed to January or February after a customer design change. Traders are split between viewing the results and customer prepayments as a basis for a rebound and focusing on execution delays, heavy capital needs and debt amid a broader selloff in AI-infrastructure stocks.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

A broad market selloff, led by tech and semiconductor weakness, has weighed on the Dow as traders debate whether political pushback could slow AI and data-center investment. The community is largely bearish after the sharp decline, though some see the Dows relative resilience and rotation away from tech as a buying opportunity.

Onyxcoin (XCN) is a cryptocurrency launched in 2021and operates on the Ethereum platform. Onyxcoin has a current supply of 53,402,422,627.32441369 with 40,401,002,518.96686512 in circulation. The last known price of Onyxcoin is 0.00346216 USD and is down -2.54 over the last 24 hours. It is currently trading on 205 active market(s) with $8,013,358.10 traded over the last 24 hours. More information can be found at https://onyx.org.

Onyxcoin

XCNs sharp, volatile moves are the main focus, with many traders attributing recent weakness to Bitcoin and the broader crypto-market decline while others argue the token is underperforming or prone to pump-and-dump swings. Long-term holders are buying dips and pointing to Onyxs payments, wallet, and neobank development, while skeptics question whether those plans are translating into sustained demand.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

AMAT is selling off alongside semiconductor-equipment peers as traders worry that AI-related fab spending may slow, since equipment orders are an early signal of future chipmaker demand. The community is split between viewing the decline as an AI-capex bubble warning and treating it as a buying opportunity in a strong long-term business.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings weaker-than-expected Q3 results and reduced full-year outlook have triggered a sharp selloff, with traders focused on rising costs and heavy investment in its Predictions business. Some see that spending and customer growth as a long-term opportunity, while skeptics worry it is widening losses amid competition from Kalshi and Polymarket and regulatory uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The pullback appears tied mainly to broad market and biotech weakness, with traders citing a sharp tech selloff and declines in XBI and other sectors. Attention remains on the pending FDA decision on deramiocel, but no company-specific development is identified as triggering the move.

US Stock Futures Rise As Democrats Make Midterm Gains — AMD, SMCI, PLTR, SPCX, DJT In Focus

Equity

Oil prices also edged higher as markets awaited Washington’s next move in the war in Iran.

CAPR Stock Rises As Clinical Trial Investigators Write To FDA Urging Approval For Deramiocel 

The FDA is slated to decide on approving Capricor’s drug for the treatment of Duchenne muscular dystrophy by November 22.

FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight 

November brings several closely watched FDA decisions, with Regeneron and its partner Alnylam’s therapy for generalized myasthenia gravis and Roche’s Gazyva for primary membranous nephropathy in the spotlight this week.


CAPR Stock Rallies Into FDA Decision Month: Retail Spots Approval ‘Tea Leaves’ In Capricor’s Launch Team Hiring

Capricor is recruiting two commercial bosses, with both listings for the preparations for a potential Deramiocel launch.

Commit To Buy Capricor Therapeutics At $3, Earn 69.5% Annualized Using Options

Investors considering a purchase of Capricor Therapeutics Inc (Symbol: CAPR) shares, but cautious about paying the going market price of $6.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...

CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears

The FDA is slated to decide on approving Capricor’s Deramiocel for the treatment of Duchenne muscular dystrophy by November 22.


CAPR Stock Rises Nearly 5% As Capricor Presents Heart Data For Deramiocel Ahead Of November FDA Decision

Craig McDonald said on Wednesday that in patients in the HOPE-3 trial with weakened hearts, Deramiocel treatment produced “essentially complete stabilization” over a year. 


Capricor’s DMD Therapy Shows 76% Slower Upper-Limb Decline — This Analyst Expects A Complete Response Letter In November

Capricor’s Phase 3 HOPE-3 open-label extension data shows significant improvement in upper limb decline, but H.C. Wainwright said it did not remove the statistical uncertainty from the original trial.

CAPR Stock Clocks Best Day In Over A Month As 24-Month Duchenne Data Airs At Medical Conference In Japan

The company is slated to orally present long-term trial results of deramiocel at the World Muscle Society congress in Hiroshima on October 3.


Capricor Therapeutics Stock Surges: What's Going On?

Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are trading higher Wednesday morning following the release of positive long-term clinical data for its lead cellular therapy. read more...

Bullish Sentiment

<ul class="summary-bullets"><li>AMD surged more than 7% in premarket trading after beating third-quarter estimates and issuing a stronger-than-expected sales forecast.</li><li>PLTR fell amid concerns over potential regulatory scrutiny of AI infrastructure.</li><li>SpaceX and Trump Media also declined after Democrats gained ground in the midterm elections.</li></ul>U.S. stock futures were in the green early on Wednesday as investors assessed the impact of Democrats gaining control of Congress and securing many important gubernatorial victories in the 2026 midterm elections.The Democrats’ takeover of the Senate marks a major setback for Republicans in Washington and sets the stage for greater congressional opposition to President Donald Trump.As of 3:15 a.m. ET, S&amp;P 500 futures were up 0.18%, while Nasdaq-100 futures were 0.09% higher. Dow Jones Industrial Average futures gained 0.5%. All three major index futures had recovered from their session lows.In the previous session on Tuesday, U.S. stocks&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/s-and-p-500-nasdaq-recover-from-ai-rout-on-us-midterm-election-day-meta-aapl-amd-skhy-in-focus/cNGXlSbR9dS">ended mostly higher</a>, with technology and semiconductor shares leading a recovery. The S&amp;P 500 gained 0.4%, while the Nasdaq-100 advanced 0.7%. The Dow Jones Industrial Average slipped 0.4%, while the small-cap Russell 2000 added 0.2%.<h2 class="st-heading-2">Oil Gains As Markets Await Next Move On Iran War</h2>Oil prices rose on Wednesday in a volatile trading session as investors awaited Washington’s next move in the war with Iran, while Democrats captured control of the U.S. Congress from Trump’s Republicans in the midterm elections.Brent crude futures rose 0.35%, to $103.95 a barrel at 3.15 a.m. ET. US West Texas Intermediate (WTI) crude futures gained 0.02%, to $96, reversing earlier losses.In the previous session, Brent settled at its lowest level in nearly four weeks as traders weighed prospects of talks to end the wars in Ukraine and Iran.<h2 class="st-heading-2">The Tech Radar</h2>Palantir Technologies (PLTR):&nbsp;Shares fell 2.3% in early premarket trading on Wednesday, extending their decline despite the company delivering upbeat quarterly results on Monday. The stock came under pressure alongside the broader market amid concerns that a potential Democratic majority in Congress could bring tighter regulations for data centers, threatening to constrain the expansion of AI infrastructure. Palantir also faces broader investor concerns about whether record AI spending can be sustained and whether the sector's rapid sales growth and valuation gains can continue.Advanced Micro Devices (AMD): Strong quarterly results and an upbeat sales outlook sent AMD shares up more than 7% in early premarket trading on Wednesday. The chipmaker forecast fourth-quarter sales above Wall Street estimates and said it expects revenue to grow 80% in 2027, driven by robust demand for data-center chips. AMD’s December-quarter sales forecast also topped Intel’s (INTC) outlook issued last week. If both companies meet their targets, AMD would outsell Intel for the first time in their history.Navitas Semiconductor (NVTS): The power chip maker reported better-than-expected third-quarter results on Tuesday and issued a fourth-quarter sales forecast that also topped expectations. The company expects mobile and low-end consumer revenue to nearly disappear from its mix by year-end as it sharpens its focus on high-power applications. AI infrastructure, including data centers and the energy grid systems that support them, is expected to account for more than 40% of total revenue. Navitas shares were up 4% in early premarket trading on Wednesday.Super Micro Computer (SMCI):&nbsp;Shares rose more than 6% in early premarket trading on Wednesday, a day after the company reported quarterly revenue of $19.9 billion, up 298% from $5 billion a year earlier. The figure beat both its earlier estimate and Wall Street expectations, driven by strong demand for AI-powered servers.<h2 class="st-heading-2">Trending Stocks</h2>SpaceX (SPCX):&nbsp;Democratic gains in the midterm elections have raised concerns among investors about potentially tighter congressional scrutiny of SpaceX, its government contracts and plans to expand its data-center operations. Questions over Elon Musk’s high-profile involvement in the elections and the possible implications for the company’s government business, AI subsidies and regulatory outlook also weighed on sentiment. SpaceX shares fell nearly 4.5% in early premarket trading on Wednesday.Trump Media &amp; Technology Group (DJT): Shares fell more than 7% in the premarket session as Democrats made gains in the midterm elections, dealing a political setback to President Donald Trump. Investors are concerned that a shift in control of Congress could lead to political gridlock and affect the administration’s agenda. Retail sentiment on Stocktwits was ‘extremely bearish’, with much of the discussion focusing on how the Iran war may have contributed to Republican losses and what the election results could mean for the company.Capricor Therapeutics (CAPR): The stock was in focus in early premarket trading on Wednesday, down 0.12%, after gaining in the previous session. A public letter from clinical investigators had drawn attention to the company ahead of a key FDA decision on its experimental therapy, Deramiocel. The FDA is expected to decide by November 22 whether to approve the drug for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle weakness, primarily in boys.Tesla (TSLA) and Novo Nordisk A/S (NVO) were among the other trending tickers on Stocktwits at the time of writing.<h2 class="st-heading-2">What Else To Watch On Wednesday&nbsp;</h2>A busy earnings calendar awaits on Wednesday, with Circle (CRCL), McDonald’s (MCD), Arm Holdings (ARM), Qualcomm (QCOM) and Uber Technologies (UBER) scheduled to report results.CVS Health (CVS) will also be in focus after many reports said the pharmacy chain was planning to split into two publicly traded companies by 2028.On the economic calendar, investors will be watching the October ADP employment report, S&amp;P Global Services and Composite PMIs, and the ISM Services PMI.<h2 class="st-heading-2">SPY, QQQ, DIA: Retail Sentiment</h2>Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, which tracks the S&amp;P 500, and&nbsp; <a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a>, which tracks the Nasdaq 100, remained ‘bearish,’ unchanged over the past 24 hours. Meanwhile, the sentiment toward&nbsp; <a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> was ‘neutral’ at the time of writing.&nbsp;Also read:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/midterm-election-impact-spcx-asts-rklb-musk-political-tesla-spacex-merger-scrutiny/cNGLRztR9dU">Midterm Election Impact: SPCX, ASTS, RKLB Stocks Sink As Musk’s Political Ties Put Tesla-SpaceX Merger Under Fresh Scrutiny</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

The Nasdaq logo is displayed on a tablet screen. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

S&P 500, Nasdaq Futures Rise Premarket As Democrats Make Midterm Gains — AMD, SMCI, PLTR, SPCX, DJT In Focus

Advanced Micro Devices Inc

Trump Media & Technology Group Corp.

Navitas Semiconductor Corp

Palantir Technologies Inc

Super Micro Computer Inc

SpaceX

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Stocktwits

Stocktwits Polls

Traders are intensely monitoring the November 22 PDUFA date as they await the FDA approval decision for Deramiocel.

With heavy short interest and aggressive call buying, investors are tracking potential trigger points that could force significant MM hedging.

Speculation surrounds the ongoing arbitration and potential settlement with NS Pharma, which could hand back full US commercial rights.

Community discussions are fixated on questioning FDA integrity while rallying behind scientific data and clinical expert letters supporting the therapy.

Current Price	$8.60
Prev Close	$8.92
Open	$8.64
Dividend Yield	0.00%
50-Day Moving Average	$8.10
Beta	1.08
Avg. Volume	2.81M
PE Ratio	-3.51

52-Week High	$40.37
52-Week Low	$2.96
Market Capitalization	$518.6M
EPS (Annual)	-$2.26
Price to Book	2.03
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CAPR Fundamentals